Status:
COMPLETED
Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Sickle Cell Disease
Pain Management
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will examine whether hypnosis can reduce the frequency and intensity of pain in patients with sickle cell disease. Patients 18 years of age and older with sickle cell disease and a history...
Detailed Description
Sickle cell disease (SCD) is the most common genetic disease in African-Americans, characterized by recurrent painful vaso-occlusive crises. Standard medical therapies for controlling or preventing cr...
Eligibility Criteria
Inclusion
- ELIGIBILITY:
- Subjects with known or suspected sickle cell disease are eligible to participate in this study.
- INCLUSION CRITERIA:
- Greater than or equal to 18 years of age.
- Diagnosis of Hemoglobin SS sickle cell disease.
- Patient identifies history of pain as a significant problem during at least 2 days in the month prior to enrollment.
- Written informed consent/assent has been obtained.
- \<TAB\>
- EXCLUSION CRITERIA:
- Less than 18 years of age.
- Unwilling to experience hypnosis or to have hetero-hypnosis sessions recorded.
- Non-fluency in written and spoken English.
- Physical or other disabilities that prevent adequate participation in hypnotic susceptibility testing.
- Does not wish to be video and audiotaped.
- Psychosis or psychotic depression.
- History of seizures or epilepsy.
Exclusion
Key Trial Info
Start Date :
April 30 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2012
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00393250
Start Date
April 30 2007
End Date
June 4 2012
Last Update
October 29 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Howard University Hospital
Washington D.C., District of Columbia, United States, 20060
2
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892